Here, we demonstrate that the improved muscle mass and strength upon administration of ACVR2B/Fc was also associated with improvement in Stat3 phosphorylation, further highlighting Stat3 as a pivotal prognosticator of cancer‐induced muscle wasting. This evidence concerns the gene STAT3 and cancer.